Little is known about the association between inflammatory biomarkers, such as interleukin‐6 (IL‐6) and C‐reactive protein (CRP) in the acute phase, and persistent symptoms after hospitalization in COVID‐19 patients. Here, IL6 is linked to COVID-19.